General Brain Chemistry:

• Gitlin MJ "Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.”    J. Clin Psychiatry 55(9): 406-13, 1994.
• Kafka MP, Prentky R "Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men."    J. Clin Psychiatry 53(10): 351-8, 1992.
• Gilberg C "Endogenous opioids and opiate antagonists in autism"    Dev. Med Child Neurol 37(3): 239-45, 1995.
• Copolov DL, Helme RD "Enkephalins and endorphins. Clinical, pharmacological and therapeutic implications"   Drugs 26(6): 503-19, 1983.
• Rosenburg GS, Davis KL "The use of cholinergic precursors in neuropsychiatric diseases"    American Journal of Nutrition, 36 (4): 709-720, Oct. 1982.
• Wood JL, Allison RG "Effects of consumption of choline and lecithin on neurological and cardiovascular systems."    Fed Proc., 41(14) 3015021, 1982.
• Kent S "Can drugs improve memory?"    Geriatrics, 34(7): 77, July 1979.
• Samorajski T "Central neurotransmistter substances and aging: a review."    J. Am. Geriatric Soc., 25(8) 337-48, Aug. 1977.
• Bartus RT, Dean RL, et al "The cholinergic hypothesis of geriatric memory dysfunction."    Science, 217 (4558): 408-14, July 1982.
• Benenger RJ, et al "Animal studies of brain acetylcholine and memory."    Arch. Gerontol. Ger. Suppl. 1:71-89, 1989.
• Chapouthier G "The search for a biochemistry of memory."    Arch Gerontol. Ger. Suppl. 1:7-19, 1989.
• Crawley JN "Functional interactions of galanin and acetylcholine:    relevance to memory and Alzheimer's disease."   Behav. Brain Res. 57(2): 133-41, 1993.
• Muir JL, et al "Excitotoxic lesions of basal forebrain cholinergic neurons:    effects on learning, memory and attention."   Behav. Brain Res. 57 (2): 123-31, 1993.
• Beck CH "Functional implications of changes in the senescent brain:    a review."   Can J. Neurol. Sci 5(4): 417-24, 1978.
• Trams EG "On the evolution of neurochemical transmission."    Differentiation 19(3): 125-33, 1981.
• Pontecorvo MJ, et al "Age-related cognitive impairments as assessed with an automated repeated measures memory task:    implications for the possible role of acetylcholine and norepinephrine in memory dysfunction."   Neuro. Aging, 9(506): 617-25, 1988.
• Hasselmo ME, Bower JM "Acetylcholine and memory."    Trends Neurosci 16(6): 218-22, 1993.
• Erlich SS, Apuzzo ML "The pineal gland:    anatomy, physiology, and clinical significance"   J. Neurosurg 63(3): 321-41, 1985.
• Power-Smith P "Beneficial sexual side effects from fluoxetine"    Br. J. Psychiatry 164(2): 249-50, 1994.
• Grad Br, Rozencwaig R "The role of melatonin and serotonin in aging"    Psychoneuroendocrinology 18(4): 283-95, 1993.
• Kral' A "The role of pineal gland in circadian rhythms regulation"    Bratisl Lek Listy 95(7): 295-303, 1994.
• McLeod SD, Cairncross KD "Preliminary evidence of a synergistic alpha 1- and beta 1- adrenoceptor regulation of rat pineal hydroxyindole-O-methyltransferase"    Gen Comp. Endocrinol, 97(3): 283-8, 1995.
• He H, Richardson JS "A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors"    Int. Clin Psycholpharmacol 10(1): 19-30, 1995.
• Pandey SC, Davis JM, Pandey GN "Phosphoinositide system-lined serotonin receptor subtypes and their pharmacological properties and clinical correlates"   J. Psychiatry Neurosci 20(3): 215-25, 1995.
• Zawilska JB "The role of dopamine in the regulation of melatonin biosynthesis in vertebrate retina"    Acta Neurobiol. Exp. 54 Suppl:47-56, 1994.
• Johnson SK, Wagner GC, Fischer H “Neurochemical and motor effects of high dose haloperidol treatment:   exacerbation by tryptophan supplementation.”   Proc Soc Exp Biol Med (1992 Sep) 200(4):571-5.
• Oak JN, Oldenhof J, Van Tol HH “The dopamine D(4) receptor:    one decade of research”   Eur J Pharmacol 2000 Sep 29;405(1-3):303-27.
• Anatomie und Zellbiologie “Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism”    J Neurosci 2000 May 15;20(10):3596-605.
• Nestby P, Vanderschuren LJ, et al “Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen”   Psychopharmacology (Berl) 1999 Jan;141(3):307-14.
• Grahame NJ, Mosemiller AK, Low MJ, Froehlich JC “Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis”   Pharmacol Biochem Behav 2000 Dec;67(4):759-766.
• Macias W, Carlson R, Rajadhyaksha A, Barczak A, Konradi “Potassium chloride depolarization mediates CREB phosphorylation in striatal neurons in an NMDA receptor-dependent manner”    Brain Res 2001 Feb 2;890(2):222-232.
• Cotrina ML, Lin JH, Lopez-Garcia JC, et al. “ATP-mediated glia signaling”    J Neurosci 2000 Apr 15;20(8):2835-44.

General Behavior

• Raskind MA, Peskind ER "Neurobiologic basis of noncognitive behavioral problems in Alzheimer disease"    Alzheimer Dis Assoc Disord 8 Suppl. 3:54-60, 1994.
• Fibiger HC, Damsma G, Day JC "Behavioral pharmacology and biochemistry of central cholinergic neurotransmission."    Adv. Exp. Med Biol, 295:399-414, 1991.
• Young SN, Pihl RO, Ervin FR “The effect of altered tryptophan levels on mood and behavior in normal human males.”    Clin Neuropharmacol 1988;11 Suppl 1:S207-15.
• Young SN “Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior.”    Can J Physiol Pharmacol 1991 Jul;69(7):893-903.
• Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V, Barbaccia M, Guidotti A, Costa E, Linnoila M “Pathological gambling.    A psychobiological study.”   Arch Gen Psychiatry 1988 Apr;45(4):369-73.
• Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J “Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene.”   Pharmacogenetics 1997 Oct;7(5):345-8.
• Bergh C, Eklund T, Sodersten P, Nordin C “Altered dopamine function in pathological gambling.”    Psychol Med 1997 Mar;27(2):473-5.
• Schmitt LH, Harrison GA, Spargo RM “Variation in epinephrine and cortisol excretion rates associated with behavior in an Australian Aboriginal community.”   Am J Phys Anthropol 1998 Jun;106(2):249-53.
• Bassett JR, Marshall PM, Spillane R “The physiological measurement of acute stress (public speaking) in bank employees.”    Int J Psychophysiol 1987 Dec;5(4):265-73.

Depression

• Mayberg HS, Solomon DH "Depression in Parkinson's disease:    a biochemical and organic viewpoint."   Adv. Neurol 65:49-60, 1995.
• Richelson, E "Biological basis of depression and therapeutic relevance"    J. Clin Psychiatry 52 Suppl. 4-10, 1991.
• Lechin F, van der Dijs B, Orozco B, Lechin ME, Baez S, Lechin AE, Rada I, Acosta E, Arocha L, Jimenez V, et al “Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients.”    Biol Psychiatry (1995 Aug 1) 38(3):166-73.
• Eison MS "Serotonin: a common neurobiologic substrate in anxiety and depression"    J. Clin Psychopharm 10(3 Suppl):26S-30S, 1990.
• Horton RW "The neurochemistry of depression:    evidence derived from studies of post-mortem brain tissue"   Mol. Aspects Med. 13(3):191-203, 1992.
• Mitchell PB "Selective serotonin reuptake inhibitors:    adverse effects, toxicity and interactions"   Adverse Drug React Toxicol Rev. 13(3): 121-44, 1994.
• Fuller RW, Wong DT "Serotonin uptake and serotonin uptake inhibition"    An NY Acad Sci 600:68-78, 1990.
• Meltzer HY "Role of serotonin in depression"    Ann NY Acad Sci 600:486-99, 1990.
• Jimerson DC, et al "Eating disorders and depression:   is there a serotonin connection?"   Biol Psychiatry 28(5):443-54, 1990.
• Cowen PJ "Serotonin receptor subtypes in depression:    evidence from studies in neuroendocrine regulation"   Clin Neuropharmacol 16 Suppl 3:S6-18, 1993.
• Murdoch D, McTavish D "Sertraline.    A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder"   Drugs 44(4):604-24, 1992.
• Deakin JF "Depression and 5HT"    Int Clin Psychopharm 6 Suppl 3:23-8, 1991.
• Baldwin D, Rudge S "The role of serotonin depression and anxiety"   Int. Clin Psychopharmacol 9 Suppl 4:41-5, 1995.
• Schatzberg AF, Rothschild AJ "Serotonin activity in psychotic major depression"    J. Clin Psychiatry 53 Suppl: 52-5, 1992.
• Risch SC, Nemeroff CB "Neurochemical alterations of serotonergic neuronal systems in depression"   J. Clin Psychiatry 53 Suppl:3-7, 1992.
• Fuller RW "Role of serotonin in therapy of depression and related disorders"    J. Clin Psychiatry 52 Suppl: 52-7, 1991.
• Hernadez L, et al "Hypothalmic serotonin in treatments for feeding disorders and depression as studied by brain microdialysis"   J. Clin Psychiatry 52 Suppl: 32-40, 1991.
• Owens MJ, Nemeroff CB "Role of serotonin in the pathophysiology of depression:    focus on the serotonin transporter"   Clin Chem. 40(2): 288-95, 1994.
• Maurizi CP "Disorder of the pineal gland associated with depression, peptic ulcers, and sexual dysfunction."    South Med J 77 (12): 1516:18, 1984.
• Lechin F, et al "Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients."    Biol Psychiatry, 38, 1995.
• Miller HL, Delgado PL, Salomon RM, Licinio J, Barr LC, Charney DS “Acute tryptophan depletion:    a method of studying antidepressant action.”   J Clin Psychiatry (1992 Oct) 53 Suppl:28-35.
• Majeroni B, Hess A “The Pharmacologic Treatment of Depression”    J of Am Board Fam Pract 11(2): 127-139, 1998.
• Peirson AR, Heuchert JW “Correlations for serotonin levels and measures of mood in a nonclinical sample.”    Psychol Rep 2000 Dec;87(3 Pt 1):707-16.
• Peirson AR, Heuchert JW, Thomala L, Berk M, Plein H, Cloninger CR “Relationship between serotonin and the temperament and character inventory.”    Psychiatry Res 1999 Dec 13;89(1):29-37.
• Van Winkle E “The toxic mind:    the biology of mental illness and violence.”   Med Hypotheses 2000 Oct;55(4):356-68.
• Boyer P, Tassin JP, Falissart B, Troy S “Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.”   J Clin Pharm Ther 2000 Oct;25(5):363-71.
• Comings DE, Blum K “Reward deficiency syndrome:    genetic aspects of behavioral disorders.”   Prog Brain Res 2000;126:325-41.
• Marazziti D, Akiskal HS, Rossi A, Cassano GB “Alteration of the platelet serotonin transporter in romantic love.”    Psychol Med 1999 May;29(3):741-5.
• Monteiro-dos-Santos PC, Graeff FG, dos-Santos JE, Ribeiro RP, Guimaraes FS, Zuardi AW “Effects of tryptophan depletion on anxiety induced by simulated public speaking.”    Braz J Med Biol Res 2000 May;33(5):581-7.

Obesity

• Bray GA, York B, DeLany J “A survey of the opinions of obesity experts on the causes and treatment of obesity.”  In: Am J Clin Nutr (1992 Jan) 55(1 Suppl):151S-154S.
• Mullen BJ, Martin RJ “The effect of dietary fat on diet selection may involve central serotonin.”    In: Am J Physiol (1992 Sep) 263(3 Pt 2):R559-63.
• Wurtman JJ "Depression and weight gain:    the serotonin connection"   J Affect Disord 29(2-3):183-92, 1993.
• Szkudlarek J, Elsborg L “Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low calorie diet.”    Int J Obes Relat Metab Disord (1993 Dec) 17(12):681-3.
• Pijl H, Koppeschaar HP, Cohen AF, Iestra JA, Schoemaker HC, Frolich M, Onkenhout W, Meinders AE “Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans.”    Int J Obes Relat Metab Disord (1993 Sep) 17(9):513-20.

Diet and Nutrition:

• Salomon RM, et al "The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders"    Int. Clin Psycholpharmacol 8 Suppl 2:41-6, 1993.
• Moller SE "Serotonin, carbohydrates, and atypical depression"    Pharmacol Toxicol 71 Suppl 1:61-71, 1992.
• Mullen BJ, Martin RJ "The effect of dietary fat on diet selection may involve central serotonin"    Am J Physiol 263, 1992.
• Delgado PL, et al "Serotonin and the neurobiology of depression.    Effects of tryptophan depletion in drug-free depressed patients"   Arch Gen Psychiatry 51, 1994.
• Venero JL, et al "Changes in neurotransmiter levels associated with the deficiency of some essential amino acids in the diet"    Br. J. Nutr 68, 1992.
• Kema IP, et al "Influence of a serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites"    Clin Chem 38, 1992.
• Miller et al "Acute tryptophan depletion:    a method of studying antidepressant action"   J Clin Psychiatry 53, 1992.
• Blum I, et al "The influence of meal composition on plasma serotonin and norepinephrine concentrations"    Metabolism 41, 1992.
• Yamauchi A, et al "Amino acids and glucose differentially increased extracellular 5-hydroxyindoleacetic acid in the rat brain"    J Nutr Sci Vitaminol, June 1995.
• Young SN "The use of diet and dietary components in the study of factors controlling affect in humans:    a review"   J Psychiatry Neuroscience, Nov. 1993.
• Castano A, et al "Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat"    Neuroscience, Mar 1993.
• Ashely DV, et al "Plasma amino acid responses in humans to evening meals of differing nutritional composition"    Am J Clin Nutr, July 1982.
• Wurtman RJ, Fernstrom JD "Control of brain monoamine synthesis by diet and plasma amino acids"    Am J Clin Nutr Jun 1975.
• Wurtman RJ, Growdon JH "Dietary enhancement of CNS neurotransmitters"    Hosp. Pract Mar, 1978.
• Tackman, et al "Dietary disproportions of amino acids in the rat:    effects on food intake, plasma and brain amino acids and brain serotonin.”   J. Nutr May, 1990.
• Dalal BB, et al "Impact of amino acid imbalance on brain amines"    Int. J Vitam Nutr Res 57, 1987.
• Moja EA, Lucini V, Benedetti F, Lucca A “Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man.”   Life Sci 1996 May 24;58(26):2389-95.
• Young SN, Ervin FR “Cerebrospinal fluid measurements suggest precursor availability and sex are involved in the control of biogenic amine metabolism in a primate.”    J Neurochem 1984 Jun;42(6):1570-3.
• Markus CR, Panhuysen G, Tuiten A, Koppeschaar H, Fekkes D, Peters ML “Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task?”    Appetite 1998 Aug;31(1):49-65.
• McTavish SF, Cowen PJ, Sharp T “Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.”    Psychopharmacology (Berl) 1999 Jan;141(2):182-8.
• Okano G, Takeda H, Morita I, Katoh M, Mu Z, Miyake S “Effect of pre-exercise fructose ingestion on endurance performance in fed men.”    Med Sci Sports Exerc 1988 Apr;20(2):105-9.
• Young SN “The use of diet and dietary components in the study of factors controlling affect in humans:    a review.”   J Psychiatry Neurosci 1993 Nov;18(5):235-44.
• Neumeister A, Praschak-Rieder N, Hesselmann B, Tauscher J, Kasper S “The tryptophan depletion test.    Basic principles and clinical relevance”   Nervenarzt 1997 Jul;68(7):556-62.
• Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS “Serotonin and the neurobiology of depression.    Effects of tryptophan depletion in drug-free depressed patients.”  Arch Gen Psychiatry (1994 Nov) 51(11):865-74.
• Venero JL, Herrera AJ, Machado A, Cano J “Changes in neurotransmitter levels associated with the deficiency of some essential amino acids in the diet.”    Br J Nutr (1992 Sep) 68(2):409-20.
• Kema IP, Schellings AM, Meiborg G, Hoppenbrouwers CJ, Muskiet FA “Influence of a serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites.”    Clin Chem (1992 Sep) 38(9):1730-6.
• Blum I, Vered Y, Graff E, Grosskopf Y, Don R, Harsat A, Raz O “The influence of meal composition on plasma serotonin and norepinephrine concentrations.”    Metabolism (1992 Feb) 41(2):137-40.
• Gietzen DW, Harris AS, Carlson S, Gelperin A “Amino acids and serotonin in Limax maximum after a tryptophan devoid diet.”    Comp Biochem Physiol A (1992) 101(1):143-9.
• Alfieri AB, Cubeddu LX “Effects of inhibition of serotonin synthesis on 5-hydroxyindoleacetic acid excretion, in healthy subjects.”   J Clin Pharmacol (1994 Feb) 34(2):153-7.
• Yamauchi A, Shizuka F, Yamamoto T, Nikawa T, Kido Y, Rokutan K, Kishi K “Amino acids and glucose differentially increased extracellular 5-hydroxyindoleacetic acid in the rat brain.”    J Nutr Sci Vitaminol (Tokyo) (1995 Jun) 41(3):325-40.
• Struder HK, Hollmann W, Platen P, Donike M, Gotzmann A, Weber K “Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans.”    Horm Metab Res 1998 Apr;30(4):188-94.
• Blomstrand E, Hassmen P, Ek S, Ekblom B, Newsholme EA “Influence of ingesting a solution of branched-chain amino acids on perceived exertion during exercise.”    Acta Physiol Scand 1997 Jan;159(1):41-9.

Activity and Brain Chemistry:

• Bache RJ, et al "Serotonin selectively aggravates subendocardial ischemia distal to a coronary artery stenosis during exercise"    Circulation 86, 1992.
• Lechin F, et al "Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients."    Biol Psychiatry Aug, 1995.
• Soares J, et al "Increased serotonin levels in physically trained men"    Braz J Med Biol Res, July 1994.
• Kinoshita A, et al "Changes of dopamine and atrial natriurectic factor by mild exercise for hypertensives"    Clin Exp Hypertens 13, 1991.
• Wilson WM, Maughan RJ "Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man:    administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise"   Exp Physiol, Nov, 1992.
• Bailey SP, et al "Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue"    J Appl Physiol, June 1993.
• Bove AA "Increased conjugated dopamine in plasma after exercise training"    J. Lab Dlin Med, July 1984.
• Chaouloff F "Physical exercise and brain monoamines:    a review"   Acta Physiol Scan Sept. 1989.
• Ratge D, et al "Free and conjugated catecholamines in human plasma during physical exercise"    Clin Exp Pharmacol Physiol, July 1986.
• Lehmann M, et al "Decreased nocturnal catecholamine excretion:    parameter for an overtraining syndrome in athletes?"   Int. J. Sports Med, Apr. 1992.
• Segura R, Ventrua JL "Effect of L-tryptophan supplementation on exercise performance"    Int J Sports Med, Oct. 1988.
• Fisher SM, et al "Influence of caffeine on exercise performance in habitual caffeine users"    Int J Sports Med, Oct. 1986.
• Jin P "Changes in heart rate, noradrenaline, cortisol and mood during Tai Chi"    J. Psychosom Res, 33, 1989.
• Sharma HS, Cervos-Navarro J, Dey PK "Increased blood-brain permeability following acute short-term swimming exercise in conscious normotensive young rats"   Neurosci. Res Apr. 1991.
• Lukaszyk A, et al "The effect of strenuous exercise on the reactivity of the central dopaminergic system in the rat"    Pol J. Pharmacol Pharm, 35:1983.
• Alves MN, Ferrari-Auarek WM, Pinto KM, Sa KR, Viveiros JP, Pereira HA, Ribeiro AM, Rodrigues LO “Effects of caffeine and tryptophan on rectal temperature, metabolism, total exercise time, rate of perceived exertion and heart rate.”    Braz J Med Biol Res 1995 Jun;28(6):705-9.
• Jackman M, Wendling P, Friars D, Graham TE “Metabolic catecholamine, and endurance responses to caffeine during intense exercise.”    J Appl Physiol 1996 Oct;81(4):1658-63.
• Tsintzas OK, Williams C, Wilson W, Burrin J “Influence of carbohydrate supplementation early in exercise on endurance running capacity.”    Med Sci Sports Exerc 1996 Nov;28(11):1373-9.
• Bell DG, Jacobs I, Zamecnik J “Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise.” Eur J Appl Physiol 1998 Apr;77(5):427-33.
• Soares J, Naffah-Mazzacoratti MG, Cavalheiro EA “Increased serotonin levels in physically trained men.”    Braz J Med Biol Res (1994 Jul) 27(7):1635-8.
• Wilson WM, Maughan RJ “Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man:    administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise.”   Exp Physiol (1992 Nov) 77(6):921-4.
• Dey S “Physical exercise as a novel antidepressant agent:    possible role of serotonin receptor subtypes.”   Physiol Behav (1994 Feb) 55(2):323-9.
• Strachan AT, Maughan RJ “Platelet serotonin transporter density and related parameters in endurance-trained and sedentary male subjects.”    Acta Physiol Scand 1998 Jun;163(2):165-71.
• Struder HK, Hollmann W, Platen P, Donike M, Gotzmann A, Weber K   “Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans.”   Horm Metab Res 1998 Apr;30(4):188-94.
• Sasaki T, Oka T, Hisanaga N, Iwasaki K “Rapid and simple analysis of urinary vanilmandelic acid by high-performance liquid chromatography with electrochemical detection.”   Ind Health 1999 Apr;37(2):213-8.
• Bush JA, Kraemer WJ, Mastro AM, Triplett-McBride NT, Volek JS, Putukian M, Sebastianelli WJ, Knuttgen HG “Exercise and recovery responses of adrenal medullary neurohormones to heavy resistance exercise.”    Med Sci Sports Exerc 1999 Apr;31(4):554-9.
• Kraemer WJ, Patton JF, Knuttgen HG, Hannan CJ, Kettler T, Gordon SE, Dziados JE, Fry AC, Frykman PN, Harman EA “Effects of high-intensity cycle exercise on sympathoadrenal-medullary response patterns.”    J Appl Physiol 1991 Jan;70(1):8-14.
• Greiwe JS, Hickner RC, Shah SD, Cryer PE, Holloszy JO “Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training.”   J Appl Physiol 1999 Feb;86(2):531-5.

• de Vries WR, Bernards NT, de Rooij MH, Koppeschaar HP “Dynamic exercise discloses different time-related responses in stress hormones”    Psychosom Med 2000 Nov;62(6):866-72.
• Goldfarb AH, Jamurtas AZ “Beta-endorphin response to exercise.   An update”   Sports Med 1997 Jul;24(1):8-16.

• Harbach H, Hell K, Gramsch C, et al “Beta-endorphin (1-31) in the plasma of male volunteers undergoing physical exercise”    Psychoneuroendocrinology 2000 Aug;25(6):551-62.
• Schwarz L, Kindermann W “Changes in beta-endorphin levels in response to aerobic and anaerobic exercise”    Sports Med 1992 Jan;13(1):25-36.

Suicide and Violence

• Coccaro EF “Impulsive aggression and central serotonergic system function in humans:    an example of a dimensional brain-behavior relationship.”   Int Clin Psychopharmacol 1992 Spring;7(1):3-12.
• Linnoila VM, Virkkunen M “Aggression, suicidality, and serotonin.”   J Clin Psychiatry 1992 Oct;53 Suppl:46-51.
• Plutchik R, Van Praag H “The measurement of suicidality, aggressivity and impulsivity.”   Prog Neuropsychopharmacol Biol Psychiatry 1989;13 Suppl:S23-34.
• Kavoussi R, Armstead P, Coccaro E “The neurobiology of impulsive aggression.”    Psychiatr Clin North Am 1997 Jun;20(2):395-403.
• Cremniter D, Despierre PG, Batista G “The risk of suicide.”    Presse Med 1998 Dec 19;27(40):2151-6.
• Hamilton MS, Opler LA "Akathisia, suicidality, and fluoxetine"   J. Clin Psychiatry 53(11):401-6, 1992.
• Golden RN, Gilmore JH, Corrigan MH, Ekstrom RD, Knight BT, Garbutt JC “Serotonin, suicide, and aggression:    clinical studies.”   J Clin Psychiatry 1991 Dec;52 Suppl:61-9.
• Nordstrom P, Asberg M “Suicide risk and serotonin.”    Int Clin Psychopharmacol 1992 Jun;6 Suppl 6:12-21.
• Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL “Serotonergic studies in patients with affective and personality disorders.    Correlates with suicidal and impulsive aggressive behavior.”   Arch Gen Psychiatry 1989 Jul;46(7):587-99.
• Staner L, Mendlewicz J “Heredity and role of serotonin in aggressive impulsive behavior”   Encephale 1998 Jul-Aug;24(4):355-64.
• Brown GL, Linnoila MI "CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence"    J. Clin Psychiatry 51 Suppl: 31-41, 1990.

• Van Winkle E “The toxic mind:    the biology of mental illness and violence”   Med Hypotheses 2000 Jan;54(1):146-56.

Brain Chemistry and OCD

• Hanna GL, Himle JA, Curtis GC, Koram DQ, Weele JV, Leventhal BL, Cook EH Jr “Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder.”    Neuropsychopharmacology 1998 Feb;18(2):102-11.
• McDougle CJ, Epperson CN, Price LH, Gelernter J “Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.”    Mol Psychiatry 1998 May;3(3):270-3.
• Sasson Y, Zohar J “New developments in obsessive-compulsive disorder research:    implications for clinical management.”   Int Clin Psychopharmacol 1996 Dec;11 Suppl 5:3-12.
• Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH “Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.”    Arch Gen Psychiatry (1994 Apr) 51(4):309-17.
• Mundo E, Bareggi SR, Pirola R, Bellodi L, Smeraldi E “Long-Term Pharmacotherapy of Obsessive-Compulsive Disorder:    A Double Blind Controlled Study”   J Clin Psycho 17(1):4-10, 1997.
• Koran LM, Sallee FR, Pallanti S “Rapid Benefit of Intravenous Loading of Clomipramine in Obsessive-Compulsive Disorder”    Am J of Psy 154(3):396-401, 1997.
• Thornton C, Russell J “Obsessive Compulsive Comorbidity in the Dieting Disorders”   Int J Eat Dis 21(1):83-87, 1997.

Brain Chemistry and ADD

• Faraone SV, Biederman J “Neurobiology of attention-deficit hyperactivity disorder.”    Biol Psychiatry 1998 Nov 15;44(10):951-8.
• Pliszka SR, McCracken JT, Maas JW “Catecholamines in attention-deficit hyperactivity disorder:    current perspectives.”   J Am Acad Child Adolesc Psychiatry 1996 Mar;35(3):264-72.
• Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J “Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder.”    Curr Opin Neurobiol 1998 Apr;8(2):263-71.
• Hechtman L “Families of children with attention deficit hyperactivity disorder:    a review.”   Can J Psychiatry 1996 Aug;41(6):350-60.
• Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA, Asarnow JR, Woodward JA, Ramsey C, Nelson SF “Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder.”    Mol Psychiatry 1998 Sep;3(5):427-30.

Nicotine

• Szir’aki I, Sershen H, Benuck M, Hashim A, Lajtha A “Receptor systems participating in nicotine-specific effects.”   Neurochem Int. 33 (5) :445-57, 1998 Nov.
• Kaye L “Pharmacologic and Behavioral Approaches to Smoking Cessation”    Hosp. Med 34 (8)41-44, 47-50, 1998.

Panic Disorder

• Goddard AW, Charney DS “Toward an Integrated Neurobiology of Panic Disorder”    J Clin Psy 58 Suppl 2:13-17, 1997.
• Cooney JM, Lucey JV, Dinan TG “Enhanced Growth Hormone Responses to Pyridostigmine Challenge in Patients with Panic Disorder”   Br J Psy 170:159-161, 1997.
• Curtis GC, Abelson JL, Gold PW “Adrenocorticotropic Hormone and Cortisol Responses to Corticotropin-Releasing Hormone:    Changes in Panic Disorder and Effects of Alpraxolam Treatment”   Bio Psy 41(1): 76-85, 1997.

Gurguis GN, Turkka J, George DT, Linnoila M “Beta-Adrenoreceptor Coupling to GS Protein in Alcohol Dependence, Panic Disorder, and Patients with Both Conditions”